Short sellers have jumped on. B&L is just enough to justify the price. It is expected to earn $10+ per share.
Stock looks very very cheap even with $30B debt with so many drugs(B&L's many OTC products,contacts, liquids, Intra Ocular lens for cataract, fungus drug, IBS drug etc.,etc., ).
They sell soft contact lenses, Intra Ocular lenses for cataract, eye allergy relief, Ocuvite, etc.These are just B&L products. What about IBS drug, fungus stuff etc.
somebody need to cut the credit rating of S&P
Mutual funds are probably selling due to end of quarter. They will comeback to buy it when it hits $100 in a month or two.
The question is will there be anything left for the common stock holders? will they give warrants or something like that which hopefully has 5 years at which time the oil might have bounced back and people may get back some money if not all.
AGN will get $40B cash rom TEVA. They will have little to no-debt. That makes it easy for them to take over VRX hopefully for a huge price.